Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» antibody-drug conjugates
antibody-drug conjugates
BeiGene, Brii and Ideaya ring in 2025 with deal news, betting billions in biobucks on prospects
Fierce Biotech
Thu, 01/2/25 - 11:28 am
BeiGene
Brii Biosciences
IDEAYA Biosciences
biobucks
antibody-drug conjugates
Roche Kicks Off 2025 Committing a Potential $1B for Another ADC From China
BioSpace
Thu, 01/2/25 - 11:37 am
Roche
China
antibody-drug conjugates
small cell lung cancer
Chasing Merck, BioNTech and DualityBio post first clinical data on ADC
Fierce Biotech
Fri, 12/6/24 - 09:39 am
Duality Biologics
antibody-drug conjugates
BioNTech
Merck
B7-H3
GSK goes East again, snagging option on preclinical DualityBio ADC for $30M
Fierce Biotech
Wed, 12/4/24 - 10:58 am
GSK
China
DualityBio
antibody-drug conjugates
Gilead looks beyond Trodelvy with Tubulis alliance
Pharmaphorum
Tue, 12/3/24 - 09:41 am
Gilead Sciences
Tubulis
antibody-drug conjugates
Adcendo licenses Multitude anti-TF ADC in $1bn+ deal
Pharmaphorum
Tue, 08/20/24 - 10:27 am
Adcendo
antibody-drug conjugates
Multitude Therapeutics
cancer
anti-TF
FDA allows BioNTech-MediLink ADC trial to resume with lower, safer doses
Fierce Biotech
Mon, 08/19/24 - 10:11 am
MediLink Therapeutics
BioNTech
clinical trials
antibody-drug conjugates
3 Big Pharma companies, 33 phase 3 trials: The race for supremacy in an ADC field
Fierce Pharma
Mon, 08/5/24 - 11:41 am
Merck
AstraZeneca
Gilead Sciences
clinical trials
antibody-drug conjugates
FDA halts trial of BioNTech-MediLink ADC over 'significant risk of illness'
Fierce Biotech
Mon, 06/17/24 - 11:48 am
FDA
MediLink Therapeutics
BioNTech
clinical trials
antibody-drug conjugates
After AbbVie's ImmunoGen buy, Elahere posts midstage trial win in ovarian cancer subtype
Fierce Pharma
Thu, 06/6/24 - 09:13 pm
AbbVie
antibody-drug conjugates
Elahere
Immunogen
Merck KGaA taps AI-focused biotech for new ADC pact worth $376M
Fierce Biotech
Tue, 06/4/24 - 11:33 am
Merck KGaA
Biolojic Design
drug discovery
antibody-drug conjugates
oncology
ASCO 2024: AbbVie flexes early success of ADC pipeline in solid tumours
Clinical Trials Arena
Mon, 06/3/24 - 12:06 pm
ASCO 2024
AbbVie
antibody-drug conjugates
Teliso-V
ABBV-400
ABBV-706
solid tumors
AstraZeneca unveils plan for $1.5bn ADC plant in Singapore
Pharmaphorum
Mon, 05/20/24 - 10:57 am
AstraZeneca
drug manufacturing
antibody-drug conjugates
Singapore
Merck KGaA signs $1.4B biobuck deal with Caris to expand ADC pipeline
Fierce Biotech
Thu, 04/4/24 - 11:17 am
Merck KGaA
oncology
antibody-drug conjugates
Caris Life Sciences